Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. MDxHealth SA
  6. Financials
    MDXH   BE0003844611

MDXHEALTH SA

(MDXH)
  Report
Real-time Euronext Bruxelles  -  11:35 2022-09-28 am EDT
0.6890 EUR   -0.14%
08/29Oppenheimer Adjusts MDxHealth Price Target to $21 From $18, Maintains Outperform Rating
MT
08/26BTIG Adjusts Price Target on MDxHealth to $15 From $13, Reiterates Buy Rating
MT
08/26MDXHEALTH SA : Half-year report
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 73,380,7138112--
Enterprise Value (EV)1 73,380,7138112112112
P/E ratio ------
Yield ------
Capitalization / Revenue 6,77x5,28x6,86x2,75x1,94x1,46x
EV / Revenue 6,77x5,28x6,86x2,75x1,94x1,46x
EV / EBITDA -2,69x-4,10x-6,41x-4,11x-5,58x-7,18x
Price to Book ------
Nbr of stocks (in thousands) 70 52990 691155 969162 881--
Reference price (EUR) 1,040,890,880,690,690,69
Announcement Date 02/26/202003/03/202103/02/2022---
1 EUR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 10,815,320,040,857,976,7
EBITDA1 -27,3-19,7-21,5-27,3-20,1-15,6
Operating profit (EBIT)1 -30,4--24,2-33,0-25,5-17,0
Operating Margin -281%--121%-80,9%-44,0%-22,1%
Pre-Tax Profit (EBT) -40,2-----
Net income -39,6--26,1---
Net margin -366%--130%---
EPS ------
Dividend per Share ------
Announcement Date 02/26/202003/03/202103/02/2022---
1 EUR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales1 3,795,796,9312,515,216,0
EBITDA1 ----6,81-6,84-6,84
Operating profit (EBIT)1 --7,45-9,20-8,33-7,35-7,08
Operating Margin --129%-133%-66,5%-48,2%-44,3%
Pre-Tax Profit (EBT) ---9,87---
Net income --7,85-9,87---
Net margin --135%-142%---
EPS ------
Dividend per Share ------
Announcement Date 12/03/202004/27/202208/25/2022---
1 EUR in Million
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow --17,2----
ROE (Net Profit / Equities) ------
Shareholders' equity ------
ROA (Net Profit / Asset) ------
Assets ------
Book Value Per Share ------
Cash Flow per Share ------
Capex 0,070,45----
Capex / Sales 0,62%2,92%----
Announcement Date 02/26/202003/03/202103/02/2022---
Previous periodNext period
Estimates
Key data
Capitalization (EUR) 112 224 964
Capitalization (USD) 108 220 795
Net sales (EUR) 20 048 460
Net sales (USD) 19 333 134
Number of employees 191
Sales / Employee (EUR) 104 966
Sales / Employee (USD) 101 221
Free-Float 83,6%
Free-Float capitalization (EUR) 93 799 906
Free-Float capitalization (USD) 90 453 140
Avg. Exchange 20 sessions (EUR) 26 265
Avg. Exchange 20 sessions (USD) 25 328
Average Daily Capital Traded 0,02%
EPS & Dividend